nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin) for Pulmonary Hypertension

"This trial is presently open to patients at 6 different sites, located in Torrance, Pittsburgh and Tucson as well as other cities. To ease the burden of travel, it would be best if you selected a clinic close to your home when signing up for this study."

"Due to a lack of clinical data, ABI-009, nab-rapamycin and albumin bound rapamycin were assigned an initial safety rating of 1. This is because the trial currently taking place is phase one and therefore has limited efficacy and safety evidence."

"ABI-009, nab-rapamycin, albumin-bound rapamycin is the go-to medication for treating organ transplantation. This pharmaceutical compound has also proven beneficial in managing liver failure, acute prophylaxis of hypovolemia and adult respiratory distress syndrome."

"Unfortunately, this trial is not enrolling new patients at the moment. It was initially put up on April 1st 2017 and amended for the last time on August 22nd 2022. If you're still searching for studies to join, there are presently 764 trials recruiting those with hypertension; 253 involving ABI-009, nab-rapamycin or albumin-bound rapamycin that are actively accepting participants."

"The information found on clinicaltrials.gov implies that this research is not currently recruiting participants; the study was first posted in April of 2017 and most recently updated August 22, 2022. Nonetheless, there are over a thousand other medical trials actively searching for members to join their experiments."